GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » E10

Genix Pharmaceuticals (TSXV:GENX) E10 : C$-0.02 (As of Oct. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genix Pharmaceuticals's adjusted earnings per share data for the three months ended in Oct. 2024 was C$0.003. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.02 for the trailing ten years ended in Oct. 2024.

During the past 5 years, the average E10 Growth Rate was -21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Genix Pharmaceuticals was 30.70% per year. The lowest was -44.20% per year. And the median was -26.00% per year.

As of today (2025-04-05), Genix Pharmaceuticals's current stock price is C$0.04. Genix Pharmaceuticals's E10 for the quarter that ended in Oct. 2024 was C$-0.02. Genix Pharmaceuticals's Shiller PE Ratio of today is .


Genix Pharmaceuticals E10 Historical Data

The historical data trend for Genix Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals E10 Chart

Genix Pharmaceuticals Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.03 -0.02

Genix Pharmaceuticals Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.02 -0.02 -0.02

Competitive Comparison of Genix Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Shiller PE Ratio falls into.


;
;

Genix Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genix Pharmaceuticals's adjusted earnings per share data for the three months ended in Oct. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Oct. 2024 (Change)*Current CPI (Oct. 2024)
=0.003/127.8378*127.8378
=0.003

Current CPI (Oct. 2024) = 127.8378.

Genix Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201501 -0.003 98.209 -0.004
201504 -0.004 99.710 -0.005
201507 -0.010 100.579 -0.013
201510 -0.010 100.500 -0.013
201601 -0.001 100.184 -0.001
201604 -0.002 101.370 -0.003
201607 -0.001 101.844 -0.001
201610 0.000 102.002 0.000
201701 -0.001 102.318 -0.001
201704 -0.001 103.029 -0.001
201707 -0.002 103.029 -0.002
201710 -0.007 103.424 -0.009
201801 0.000 104.056 0.000
201804 -0.003 105.320 -0.004
201807 0.006 106.110 0.007
201810 0.000 105.952 0.000
201901 -0.001 105.557 -0.001
201904 -0.003 107.453 -0.004
201907 -0.001 108.243 -0.001
201910 -0.001 107.927 -0.001
202001 -0.001 108.085 -0.001
202004 -0.001 107.216 -0.001
202007 -0.002 108.401 -0.002
202010 -0.010 108.638 -0.012
202101 -0.010 109.192 -0.012
202104 -0.010 110.851 -0.012
202107 -0.010 112.431 -0.011
202110 -0.010 113.695 -0.011
202201 -0.010 114.801 -0.011
202204 -0.004 118.357 -0.004
202207 -0.004 120.964 -0.004
202210 -0.010 121.517 -0.011
202301 -0.004 121.596 -0.004
202304 -0.004 123.571 -0.004
202307 -0.003 124.914 -0.003
202310 -0.060 125.310 -0.061
202401 -0.001 125.072 -0.001
202404 -0.001 126.890 -0.001
202407 -0.001 128.075 -0.001
202410 0.003 127.838 0.003

Add all the adjusted EPS together and divide 10 will get our e10.


Genix Pharmaceuticals  (TSXV:GENX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Genix Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines